Search bioRxiv⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.64898/2026.10.06.757062

Therapeutic acute intermittent hypoxia does not alter whole-brain cerebrovascular function in healthy individuals

Johnson, H. R.·Wang, M. C.·Stickland, R. C.·Chen, Y.·Parrish, T.·Sorond, F. A.·Bright, M. G.
View original source ↗Export metadata ↓

Abstract

Acute intermittent hypoxia (AIH) therapy is a promising intervention known to elicit beneficial neuroplasticity. It has been suggested that AIH may also modulate cerebrovascular function, yet the cerebrovascular effects of specific therapeutic intermittent hypoxia protocols remain poorly characterized. Understanding whether AIH results in favorable or adverse cerebrovascular changes is critical in establishing the safety of AIH treatments in populations with elevated cerebrovascular risk. This study investigated cerebral blood flow, cerebrovascular reactivity to hypoxia, and blood pressure effects in a sham-controlled crossover trial (NCT05164705). Healthy young adults (n=18) completed three-week arms of AIH (12 sessions, 15 cycles of 60 seconds hypoxia alternated with 60 seconds normoxia) and sham (6 sessions, normoxia) treatments; phase-contrast and arterial spin labeling magnetic resonance imaging were used to quantify whole-brain and regional cerebral blood flow and hypoxic cerebrovascular reactivity. Blood pressure was measured acutely (before and after each intervention session) and longitudinally (before and after 3 weeks of treatment). AIH treatment did not significantly alter whole-brain resting cerebral blood flow or cerebrovascular reactivity to hypoxia. Blood pressure was unaffected by the treatment acutely or longitudinally. Voxel-wise analysis identified modest regional perfusion increases in the frontal pole, postcentral gyri, and precentral gyri with AIH relative to sham. Significant variability between subjects and between sessions in the hypoxic burden delivered with this AIH protocol was also identified. Overall, this three-week therapeutic AIH protocol produced minimal sustained hemodynamic changes in healthy young adults. The insights from this trial lay a foundation for safely expanding access to this promising rehabilitative intervention in clinical populations.

Explore related subjects

physiologyPreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Johnson, H. R., Wang, M. C., Stickland, R. C., Chen, Y., Parrish, T., Sorond, F. A., Bright, M. G.. 2026-10-14. Therapeutic acute intermittent hypoxia does not alter whole-brain cerebrovascular function in healthy individuals. https://doi.org/10.64898/2026.10.06.757062

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

Speed judgments during smooth pursuit reflect low gain efference copy

During smooth pursuit eye movements, the visual system must compensate for self-generated retinal motion to achieve stable perception of motion in the environment. This compensation primarily depends on an efferent copy of motor commands. Systematically under- or overweighting the strength of efference copy should lead to correlations between eye movement velocity and perceived object velocity. However, previous examinations of these trial-by-trial perceptual correlations have produced mixed results. It remains unclear how effectively the brain compensates for eye movement induced retinal motion during pursuit, and what this reveals about the way efference copy influences perception. To address this, we developed a speed perturbation paradigm in which 29 participants tracked a moving target that underwent brief speed changes. On each trial, we recorded eye velocity along with perceptual judgments of the sign of the speed change (faster or slower) and confidence ratings for those judgments. Across participants, perceptual and oculomotor sensitivity were correlated (r =0.53), but trial-by-trial perceptual and oculomotor responses appeared independent. A logistic regression model incorporating efference copy gain to predict perceptual reports from stimulus speed and eye speed revealed systematic under-compensation for eye movements; faster eye movements were associated with lower changes in perceived speed. Confidence ratings were well-calibrated to perceptual accuracy and showed a consistent negative relationship with eye movement speed. Collectively, these results are consistent with systematic under compensation for eye movements through the use of efference copy during motion perception.

physiology↗
bioRxiv2026

AN INTEGRATED HEART-ON-A-CHIP NAM RESOLVES DISTINCT CLINICAL PHENOTYPES OF MYOCARDIAL ISCHEMIA-REPERFUSION INJURY

Background: Reperfusion is required for myocardial salvage yet itself injures the heart, and cardioprotective interventions that reduce infarct size experimentally have repeatedly failed to improve outcomes in patients. These interventions are evaluated against viability or infarct size alone, whereas ischemia-reperfusion (I/R) injury produces structural, biochemical, and contractile dysfunction in the same tissue. No in vitro new approach methodology (NAM), however, resolves all three within one system. Methods: A NAM was created within a heart-on-a-chip platform, which was constructed by culturing neonatal rat ventricular myocytes (NRVMs) on muscular thin films. Cardiomyocytes were subjected to normoxia, 2 hours of ischemia, and ischemia followed by 2 hours of reperfusion. Sarcomeric architecture was quantified by immunofluorescence, cardiomyocyte injury by LIVE/DEAD staining and cardiac troponin I release into conditioned media, while contractile stress and spontaneous beat frequency were recorded on the same films before and after each condition. Results: Under ischemia, z-line density decreased while architectural metrics were preserved, indicating cell loss rather than sarcomere disorganization. Furthermore, viability decreased, troponin elevated, and every contractile stress component declined, while spontaneous beat frequency was unchanged. Reperfusion fractured this uniform depression. Cell death and troponin release increased further, yet structure was unchanged from ischemia, so every functional change occurred on a depleted but architecturally intact cardiomyocyte population. Systolic stress recovered partially, whereas diastolic stress exceeded baseline, leaving active stress suppressed despite oxygen recovery. Beat frequency increased with pronounced variability. Conclusions: This heart-on-a-chip NAM resolved structural, biochemical, and contractile injury that global indices conflate, distinguishing ischemic from reperfusion pathophysiology. Interestingly, individual readouts corresponded to distinct clinical syndromes of ischemic injury, positioning this platform for future testing of cardioprotective candidates against the full injury phenotype.

physiology↗
bioRxiv2026

Proteomic profiling of experimental acute alcohol intoxication reveals FGF21 as a specific ethanol-induced hormone

Background: The effects of acute alcohol intoxication on the human plasma proteome are still largely unexplored. Gaining insights into this relationship could identify factors that are influenced by and influence alcohol consumption. Fibroblast Growth Factor 21 (FGF21), a hormone produced by the liver and associated with alcohol preferences, is currently undergoing Phase 2 clinical trials for metabolic dysfunction and alcohol-related liver disease. We hypothesized that FGF21 is a key endocrine responsive hormone to alcohol in humans. Methods: In a post hoc analysis, we evaluated the effects of five standard units of alcoholic beverages on the plasma proteome in 12 healthy Caucasian men. Participants, fasting for 10 hours, received 0.7 g of alcohol per kg of body weight via gastric infusion, with blood samples collected before and after consumption. Results: The proteomic response to this level of alcohol intoxication was highly specific. Of 1,462 proteins measured, only 11 changed significantly and FGF21 exhibited by far the largest increase (10.5-fold). Conclusion: This study highlights a unique proteomic response to acute alcohol ingestion and supports further exploration of FGF21 mimetics as potential treatments for alcohol-related disorders.

physiology↗